Green MR - Search Results

1

Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trial.

D'Cunha J, Herndon JE 2nd, Herzan DL, Patterson GA, Kohman LJ, Harpole DH, Kernstine KH, Kern JA, Green MR, Maddaus MA, Kratzke RA; Cancer and Leukemia Group B. D'Cunha J, et al. Among authors: green mr. Lung Cancer. 2005 May;48(2):241-6. doi: 10.1016/j.lungcan.2004.11.006. Epub 2005 Jan 4. Lung Cancer. 2005. PMID: 15829324 Clinical Trial.

2

A phase II trial of 6-hydroxymethylacylfulvene (MGI-114, irofulven) in patients with relapsed or refractory non-small cell lung cancer.

Sherman CA, Herndon JE 2nd, Watson DM, Green MR; Cancer and Leukemia Group B. Sherman CA, et al. Among authors: green mr. Lung Cancer. 2004 Sep;45(3):387-92. doi: 10.1016/j.lungcan.2004.02.017. Lung Cancer. 2004. PMID: 15301880 Clinical Trial.

3

Phase II trial of karenitecin in patients with relapsed or refractory non-small cell lung cancer (CALGB 30004).

Miller AA, Herndon JE 2nd, Gu L, Green MR; Cancer and Leukemia Group B. Miller AA, et al. Among authors: green mr. Lung Cancer. 2005 Jun;48(3):399-407. doi: 10.1016/j.lungcan.2004.11.019. Epub 2005 Jan 23. Lung Cancer. 2005. PMID: 15893009 Clinical Trial.

4

Results of cancer and leukemia group B protocol 8935. A multiinstitutional phase II trimodality trial for stage IIIA (N2) non-small-cell lung cancer. Cancer and Leukemia Group B Thoracic Surgery Group.

Sugarbaker DJ, Herndon J, Kohman LJ, Krasna MJ, Green MR. Sugarbaker DJ, et al. Among authors: green mr. J Thorac Cardiovasc Surg. 1995 Mar;109(3):473-83; discussion 483-5. doi: 10.1016/s0022-5223(95)70278-4. J Thorac Cardiovasc Surg. 1995. PMID: 7877308 Free article. Clinical Trial.

5

Analysis of neuroendocrine markers, HER2 and CEA before and after chemotherapy in patients with stage IIIA non-small cell lung cancer: a Cancer and Leukemia Group B study.

Graziano SL, Kern JA, Herndon JE, Tatum A, Brisson ML, Memoli V, Sugarbaker D, Skarin AT, Kreisman H, Green MR. Graziano SL, et al. Among authors: green mr. Lung Cancer. 1998 Sep;21(3):203-11. doi: 10.1016/s0169-5002(98)00063-4. Lung Cancer. 1998. PMID: 9857998 Clinical Trial.

6

Use of neuroendocrine markers, p53, and HER2 to predict response to chemotherapy in patients with stage III non-small cell lung cancer: a Cancer and Leukemia Group B study.

Graziano SL, Tatum A, Herndon JE 2nd, Box J, Memoli V, Green MR, Kern JA. Graziano SL, et al. Among authors: green mr. Lung Cancer. 2001 Aug-Sep;33(2-3):115-23. doi: 10.1016/s0169-5002(01)00183-0. Lung Cancer. 2001. PMID: 11551406

7

Therapy choices among older patients with lung carcinoma: an evaluation of two trials of the Cancer and Leukemia Group B.

Rocha Lima CM, Herndon JE 2nd, Kosty M, Clamon G, Green MR. Rocha Lima CM, et al. Among authors: green mr. Cancer. 2002 Jan 1;94(1):181-7. doi: 10.1002/cncr.10174. Cancer. 2002. PMID: 11815975 Free article. Clinical Trial.

8

Aberrant p53 staining does not predict cisplatin resistance in locally advanced non-small cell lung cancer.

Johnson EA, Klimstra DS, Herndon JE 2nd, Catalano E, Canellos GP, Graziano SL, Kern JA, Green MR. Johnson EA, et al. Among authors: green mr. Cancer Invest. 2002;20(5-6):686-92. doi: 10.1081/cnv-120003537. Cancer Invest. 2002. PMID: 12197224

9

Immunohistochemical detection of occult lymph node metastases in non-small cell lung cancer: anatomical pathology results from Cancer and Leukemia Group B Trial 9761.

Vollmer RT, Herndon JE 2nd, D'Cunha J, Abraham NZ, Solberg J, Fatourechi M, Maruska A, Kern JA, Green MR, Kratzke RA, Maddaus MA; Cancer and Leukemia Group B Trial 9761. Vollmer RT, et al. Among authors: green mr. Clin Cancer Res. 2003 Nov 15;9(15):5630-5. Clin Cancer Res. 2003. PMID: 14654545

10

Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807).

Otterson GA, Herndon JE 2nd, Watson D, Green MR, Kindler HL; Cancer and Leukemia Group B. Otterson GA, et al. Among authors: green mr. Lung Cancer. 2004 May;44(2):251-9. doi: 10.1016/j.lungcan.2003.10.011. Lung Cancer. 2004. PMID: 15084390 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

900 results

Search Page

Filters